Literature DB >> 23981576

Hepatitis B virus-induced hepatocellular carcinoma.

Cheng Xu1, Wence Zhou2, Yuming Wang3, Liang Qiao4.   

Abstract

Many factors are considered to contribute to hepatitis B virus (HBV) associated hepatocellular carcinoma (HCC), including products of HBV, HBV integration and mutation, and host susceptibility. HBV X protein (HBx) can interfere with several signal pathways that associated with cell proliferation and apoptosis, and the impact of HBx C-terminal truncation in the development of HCC has been implicated. Recent studies by advanced sequencing technologies have revealed recurrent HBV DNA integration sites in hepatoma cells and susceptible genes/SNPs play an important role in the pathogenesis of liver cancer. Epigenetic changes, immune and inflammatory factors are also important contributing factors for liver cancer. This mini-review provides an overview on the recent development of HBV induced HCC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; HBV; HBVx; HCC

Mesh:

Substances:

Year:  2013        PMID: 23981576     DOI: 10.1016/j.canlet.2013.08.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  58 in total

1.  Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis.

Authors:  Xin-Sen Xu; Yong Wan; Si-Dong Song; Wei Chen; Run-Chen Miao; Yan-Yan Zhou; Ling-Qiang Zhang; Kai Qu; Si-Nan Liu; Yue-Lang Zhang; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.

Authors:  G X Feng; J Li; Z Yang; S Q Zhang; Y X Liu; W Y Zhang; L H Ye; X D Zhang
Journal:  Oncogene       Date:  2017-08-28       Impact factor: 9.867

4.  MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection.

Authors:  Er-Lei Zhang; Jin Gu; Zun-Yi Zhang; Ke-Shuai Dong; Bin-Yong Liang; Zhi-Yong Huang
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

5.  Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.

Authors:  Xian Lin; Ai-Min Li; Yong-Hao Li; Rong-Cheng Luo; Zhen Liu; Yu-Jiao Zou; Yi-Yi Liu; Chen Liu; Ying-Ying Xie; Shi Zuo; Zhan Liu; Wei-Yi Fang
Journal:  Signal Transduct Target Ther       Date:  2020-02-14

6.  Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.

Authors:  Y E Tian; X U Xie; Yao Lin; Guang Tan; W U Zhong
Journal:  Oncol Lett       Date:  2015-03-10       Impact factor: 2.967

7.  The expression and role of lncRNA AX800134 in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Kai Zuo; Li Kong; Dong Xue; Yanyan Yang; Linlin Xie
Journal:  Virus Genes       Date:  2018-05-22       Impact factor: 2.332

Review 8.  Establishment of animal models with orthotopic hepatocellular carcinoma.

Authors:  Tai Kyoung Lee; Kyung Sook Na; Jeonghun Kim; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2014-07-29

9.  Follicular helper T cell exhaustion induced by PD-L1 expression in hepatocellular carcinoma results in impaired cytokine expression and B cell help, and is associated with advanced tumor stages.

Authors:  Zun-Qiang Zhou; Da-Nian Tong; Jiao Guan; Hung-Wu Tan; Lu-Don Zhao; Ying Zhu; Jing Yao; Jun Yang; Zheng-Yun Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

Review 10.  MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.

Authors:  Sirio Fiorino; Maria Letizia Bacchi-Reggiani; Michela Visani; Giorgia Acquaviva; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Luca Di Tommaso; Arrigo Bondi; Sergio Sabbatani; Andrea Domanico; Carlo Fabbri; Paolo Leandri; Annalisa Pession; Elio Jovine; Dario de Biase
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.